Cetera Advisor Networks’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Cetera Advisor Networks’s Portfolio CRXT Stock Details CRXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-63,000	Closed	-$24K	–	2211
2022 Q2	$24K	Buy	+63,000	New	+$44.1K	﹤0.01%	2029

Other funds holding CRXT

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Cetera Advisor Networks's CRXT Position: Q3 2022 in Review

Cetera Advisor Networks sold out of Clarus Therapeutics Holdings, Inc. Common Stock (CRXT) in Q3 2022, closing a stake of 63,000 shares — an estimated $24K sold.

Cetera Advisor Networks first reported a position in CRXT in Q2 2022 and held it in 1 quarter. The position peaked at $24K in Q2 2022. 2 funds tracked by Wall St. Rank hold CRXT as of Q3 2022.

Cetera Advisor Networks reported no remaining Clarus Therapeutics Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Cetera Advisor Networks sold 63,000 Clarus Therapeutics Holdings, Inc. Common Stock shares in Q3 2022, an estimated $24K.
Cetera Advisor Networks first reported a position in Clarus Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Cetera Advisor Networks's Clarus Therapeutics Holdings, Inc. Common Stock position peaked at $24K in Q2 2022.
2 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Common Stock as of Q3 2022.

Based on Cetera Advisor Networks's 13F filing for Q3 2022, filed 14 Nov 2022.